Cover Image

Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors

Alberto F Rubio-Guerra1, David Castro-Serna2, Cesar I Elizalde Barrera2, Luz M Ramos-Brizuela21Metabolic and Research Clinic, 2Internal Medicine Department, Hospital General de Ticomán SS DF, MéxicoAbstract: Recent guidelines for the management of hypertension recommend target...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alberto F Rubio-Guerra (Author), David Castro-Serna (Author), Cesar I Elizalde Barrera (Author), et al (Author)
Format:	Book
Published:	Dove Medical Press, 2009-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015)

COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016)

ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION
by: N. A. Dzhaiani
Published: (2015)

ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION
by: N. A. Dzhaiani
Published: (2015)

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
by: O. V. Dralova, et al.
Published: (2016)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015)

Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
by: Róbert Gáspár, et al.
Published: (2013)

COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
by: Selçuk Şen, et al.
Published: (2020)

Chinese patent medicine combined with calcium channel blockers in the treatment of essential hypertension:a Bayes network meta-analysis and systematic review
by: Liangyu Cui, et al.
Published: (2024)

Calcium Channel Blocker Overdose Simulation
by: Michael Maniaci, et al.
Published: (2015)

Discovery and Development of Calcium Channel Blockers
by: Théophile Godfraind
Published: (2017)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
by: Huijin Lee, et al.
Published: (2024)

Antiarrhythmic calcium channel blocker verapamil inhibits trek currents in sympathetic neurons
by: S. Herrera-Pérez, et al.
Published: (2022)

THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017)

THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015)

Are calcium channel blockers related to lung cancer?
by: Ratchanon Rattanathanoo, et al.
Published: (2023)

Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor
by: Bin Wang, et al.
Published: (2022)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015)

THE EFFICACY OF COMBINED PHARMACOLOGICAL BLOCKING OF RAAS IN CHILDREN WITH CHRONIC RENAL DISEASE
by: E.S. Otroshchenko, et al.
Published: (2010)

THE EFFICACY OF COMBINED PHARMACOLOGICAL BLOCKING OF RAAS IN CHILDREN WITH CHRONIC RENAL DISEASE
by: E.S. Otroshchenko, et al.
Published: (2010)

The use of calcium channel blockers in the treatment of cardiovascular diseases
by: Đokić Mirjana
Published: (2015)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
by: Steffi A. Maria, MD, et al.
Published: (2023)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
by: Haotian Ma, et al.
Published: (2021)

Effect of calcium channel blockers on gingival tissues in hypertensive patients in Lagos, Nigeria: A pilot study
by: Kehinde Adesola Umeizudike, et al.
Published: (2017)

An association between calcium channel blocker and breast cancer in patients with hypertension: A case-control study
by: Ratchata Supannaroj, et al.
Published: (2023)

Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD
by: Marina P. C. Maires, et al.
Published: (2022)

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
by: Kiuchi S, et al.
Published: (2015)

Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis
by: Edinson Dante Meregildo-Rodriguez, et al.
Published: (2024)

Calcium-Channel-Blocker-Influenced Gingival Enlargement: A Conundrum Demystified
by: Pallavi Tonsekar, et al.
Published: (2021)

Calcium channel blockers- Induced iatrogenic gingival hyperplasia: Case series
by: G Agnes Golda Priyadarshini, et al.
Published: (2023)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016)

AMBIGUITIES IN DIETARY ANTIOXIDANT SUPPLEMENTATION COMPARED TO CALCIUM CHANNEL BLOCKERS THERAPY
by: Théophile eGodfraind, et al.
Published: (2015)

Comparing the Efficacy of Angiotensin Converting Enzyme Inhibitors with Calcium Channel Blockers on the Treatment of Diabetic Nephropathy: A Meta-Analysis
by: Zhaowei ZHANG, et al.
Published: (2019)

Effect of L/N-type Calcium Channel Blocker (Cilnidipine) on Oxidative Stress in Nitric Oxide-Deficient Hypertensive Rats
by: Gouher Banu Shaikh, et al.
Published: (2020)

Combination therapy in the treatment of hypertension
by: Alberto Francisco Rubio-Guerra
Published: (2018)

Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease
by: Dominik G. Haider, et al.
Published: (2015)